As glucose levels increased, sepsis-related mortality also increased: 0.9% in the euglycemic group, 3.5% in the mild hyperglycemia group, and 19.3% in the overt hyperglycemia group. Hyperglycemia is a ...

The highest risks were observed for bladder cancer, leukemia, nonmelanoma skin cancer, and kidney cancer. Patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) have a ...

Patients with AATD had a 1.6-fold higher risk of any type of middle ear surgery, even after adjusting for age, sex, COPD, and liver cirrhosis. Patients with alpha-1 antitrypsin deficiency (AATD) are ...

The patient was diagnosed with primary diffuse large B-cell lymphoma (DLBCL) of the optic nerve based on histopathologic analysis of biopsy. Researchers from Poland reported the case of a patient with ...

The short-supervised group used CPAP fewer hours per night and had lower adherence adjusted for age-specific sleep needs. Two different strategies for continuous positive airway pressure (CPAP) ...

At the time of diagnosis, patients with different types of [cardiac amyloidosis] had distinct echocardiographic presentation and survival differed in the first 3 years. Differences in ...

Rare Disease Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve patient ...

Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare acquired autoimmune neurological disorder in which both T-cell-mediated and humoral immune mechanisms target healthy myelinated ...

Between 1970 and 1995, the incidence of new NHL cases increased. Between 2007 and 2016, new cases declined by approximately 0.9% per year, and mortality from NHL decreased by 2.2% per year. 3 ...

Gastrointestinal involvement in systemic mastocytosis (SM) is a common complication and often leads to endoscopic findings. Gastrointestinal (GI) symptoms are the second most frequent clinical ...

Given the multiple genetic mutations typically present in SM-AHN, optimal approaches for SM-AHN remain elusive. A new review article has been published by Dr. Deepti H. Radia, a British clinician who ...

New research indicates that obinutuzumab is a potentially effective and cost-effective treatment for patients with rituximab-resistant AAV. Obinutuzumab therapy demonstrated immunological superiority ...